114 related articles for article (PubMed ID: 1332926)
1. Anti-elastin antibodies in patients with lung cancer.
Gmiński J; Mykała-Cieśla J; Machalski M; Drózdz M
Immunol Lett; 1992 Jul; 33(2):211-5. PubMed ID: 1332926
[TBL] [Abstract][Full Text] [Related]
2. Measurement and evaluation of serum anti-p53 antibody levels in patients with lung cancer at its initial presentation: a prospective study.
Segawa Y; Kageyama M; Suzuki S; Jinno K; Takigawa N; Fujimoto N; Hotta K; Eguchi K
Br J Cancer; 1998 Sep; 78(5):667-72. PubMed ID: 9744508
[TBL] [Abstract][Full Text] [Related]
3. Development of antibodies against p53 in lung cancer patients appears to be dependent on the type of p53 mutation.
Winter SF; Minna JD; Johnson BE; Takahashi T; Gazdar AF; Carbone DP
Cancer Res; 1992 Aug; 52(15):4168-74. PubMed ID: 1322237
[TBL] [Abstract][Full Text] [Related]
4. Alloantibodies, autoantibodies, and immune complexes in patients with lung cancer.
Górny MK; Lawniczak M; Jenek R; Słowik-Gabryelska A; Kaczmarek E; Zeromski J
Lung; 1988; 166(2):97-105. PubMed ID: 2835557
[TBL] [Abstract][Full Text] [Related]
5. Tumor-associated immunoglobulins in pulmonary carcinoma.
Gerstl B; Eng LF; Bigbee JW
Cancer Res; 1977 Dec; 37(12):4449-55. PubMed ID: 200349
[TBL] [Abstract][Full Text] [Related]
6. Immunoglobulins and complement components levels in patients with lung cancer.
Gmiński J; Mykała-Cieśla J; Machalski M; Drózdz M; Najda J
Rom J Intern Med; 1992; 30(1):39-44. PubMed ID: 1323139
[TBL] [Abstract][Full Text] [Related]
7. Immunology of elastin: study of anti-elastin peptide antibodies by DOT immunobinding assay.
Bako G; Jacob MP; Fulop T; Foris G; Leovey A; Robert L
Immunol Lett; 1987 Jul; 15(3):187-92. PubMed ID: 3311975
[TBL] [Abstract][Full Text] [Related]
8. Lung carcinoma-reactive antibodies isolated from tumor tissues and pleural effusions of lung cancer patients.
Paluch E; Ioachim HL
J Natl Cancer Inst; 1978 Aug; 61(2):319-25. PubMed ID: 79656
[TBL] [Abstract][Full Text] [Related]
9. Fine tuning of epitopic dominance induced by lung cancer on the IgG response to bovine betalactoglobulin: towards a paraneoplastic immune marker.
Michils A; Lambert JP; Yernault JC; Fabry V; Gossart B; Duchateau J
Cancer; 1996 Feb; 77(4):657-64. PubMed ID: 8616757
[TBL] [Abstract][Full Text] [Related]
10. [Anti-elastin antibodies in systemic lupus erythematosus].
Gmiński J; Poborski W; Kasprzak A; Drózdz M; Kardaszewicz E; Machalski M
Pol Tyg Lek; 1990 Jun 18-25; 45(25-26):513-5. PubMed ID: 2287568
[TBL] [Abstract][Full Text] [Related]
11. [McAb LC-1 against human lung cancer].
Ge XR; Wang J; Lin SJ; Yu NX; Che YF; Gu Y
Shi Yan Sheng Wu Xue Bao; 1989 Sep; 22(3):359-65. PubMed ID: 2555985
[TBL] [Abstract][Full Text] [Related]
12. [Demonstration of antibodies against tumor-associated antigens in the serum patients with bronchogenic carcinoma using anticomplement immunofluorescence on xenotransplants of human tumors].
Stiller-Winkler R; Stark M; Idel H
Zentralbl Bakteriol Mikrobiol Hyg B; 1985 Mar; 180(4):381-93. PubMed ID: 2988233
[TBL] [Abstract][Full Text] [Related]
13. Detection of a novel lung adenocarcinoma--associated serum antigen defined by two monoclonal antibodies, KM 432 and KM 227.
Shitara K; Hanai N; Yoshida H
Anticancer Res; 1993; 13(3):579-86. PubMed ID: 7686360
[TBL] [Abstract][Full Text] [Related]
14. Monoclonal antibodies specific for two different histological types of human lung carcinoma.
Saji S; Zylstra S; Schepart BS; Ghosh SK; Jou YH; Takita H; Bankert RB
Hybridoma; 1984; 3(2):119-29. PubMed ID: 6090307
[TBL] [Abstract][Full Text] [Related]
15. Immunocompetence in lung cancer. Relationship to extent of tumor burden and histologic type.
Pillai MR; Balaram P; Padmanabhan TK; Abraham T; Hareendran NK; Nair MK
Cancer; 1989 Nov; 64(9):1853-8. PubMed ID: 2551475
[TBL] [Abstract][Full Text] [Related]
16. Serum factors inhibiting E-rosette formation in patients with lung malignancies.
Saiz-Garcia F; Rodriguez-Valverde V
Bull Cancer; 1981; 68(4):346-9. PubMed ID: 6274454
[No Abstract] [Full Text] [Related]
17. Circulating antineuronal antibodies in small cell lung cancer.
Popp W; Drlicek M; Grisold W; Zwick H
Lung; 1988; 166(4):243-51. PubMed ID: 2849699
[TBL] [Abstract][Full Text] [Related]
18. A comparison of lung cancer antigens.
Hollinshead AC; Sega E; Stewart TH; Ricci C; Mineo TC
Tumori; 1975; 61(2):125-8. PubMed ID: 179173
[No Abstract] [Full Text] [Related]
19. Shift in the IgG subclass distribution in patients with lung cancer.
Klotz M; Blaes F; Funke D; Kalweit G; Schimrigk K; Huwer H
Lung Cancer; 1999 Apr; 24(1):25-30. PubMed ID: 10403691
[TBL] [Abstract][Full Text] [Related]
20. Lung cancer-reacting human recombinant antibody AE6F4: potential usefulness in the sputum cytodiagnosis.
Shoji M; Kawamoto S; Seki K; Teruya K; Setoguchi Y; Mochizuki K; Kato M; Hashizume S; Hanagiri T; Yoshimatsu T; Nakanishi K; Yasumoto K; Nagashima A; Nakahashi H; Suzuki T; Imai T; Shirahata S; Nomoto K; Murakami H
Hum Antibodies Hybridomas; 1996; 7(1):27-36. PubMed ID: 8886834
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
